165 results on '"Guaschino, Elena"'
Search Results
2. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls
3. Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile
4. Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
5. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls
6. Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
7. Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
8. The Virtual “Enfacement Illusion” on Pain Perception in Patients Suffering from Chronic Migraine: A Study Protocol for a Randomized Controlled Trial
9. Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients
10. Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients
11. Additional file 1 of Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
12. Sexual Function and Distress in Women Treated for Primary Headaches in a Tertiary University Center
13. Facial expressions modulate pain perception in patients with chronic migraine
14. Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: A double-blind, placebo-controlled, cross-over study
15. Periaqueductal gray matter (PAG) in migraine: Transcranial sonography study
16. Real life experience of one year treatment with Galcanezumab in chronic migraine with and without medication overuse headache
17. Psychological distress and alexithymia in chronic migraine and fibromyalgia: A comparative study
18. Evaluation of psychological predictors of real-life experience with erenumab in chronic migraine with or without medication overuse: Data from a 1-year follow-up
19. One-year treatment with erenumab: How does it affect chronic migraine in difficult-to-treat patients?
20. BONT-A efficacy in high frequency migraine: An open label, single arm, exploratory study applying the preempt paradigm
21. Validity of the Severity of Dependence Scale for detecting dependence behaviours in chronic migraine with medication overuse
22. BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm
23. Psychological Predictors of Negative Treatment Outcome with Erenumab in Chronic Migraine: Data From an Open Label Long-Term Prospective Study
24. Positive Facial Expression for Pain Modulation in Patients with Chronic Migraine
25. Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
26. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism
27. Meeting patient expectations in migraine treatment: what are the key endpoints?
28. P008. Alexithymia and chronic migraine with medication overuse: what relationship?
29. P043. Hyperechogenicity of the periaqueductal gray in chronic migraine and episodic migraine as a potential marker of progressive dysfunction: preliminary results with transcranial sonography
30. O012. Intra-variability of the characteristics of migraine attacks
31. O010. Migraine aura symptoms last for more than one hour in more than one quarter of patients: results from a prospective diary-aided study
32. O011. Patients with “prolonged aura” do not show clinical or demographic differences from the patients with “typical aura”
33. Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
34. Risk factors in medication overuse headache: A one-year follow-up study
35. Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study from the Italian National Headache Registry (RICe)
36. Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study
37. Investigating the Effects of COVID-19 Quarantine on Migraine: Data from the Italian National Headache Registry (RICe)
38. Is Hemicrania Continua a Single Entity or the Association of Two Headache Forms? Considerations From a Case Report
39. Migralepsy: A call for a revision of the definition
40. Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study.
41. Supplementary Tables -Supplemental material for Factors associated to chronic migraine with medication overuse: A cross-sectional study
42. Noninvasive peripheral vagal nerve stimulation prevents migraine aura: A case report
43. A care pathway in medication-overuse headache: the experience of the Headache Centre in Pavia
44. Clinical Subtypes of Medication Overuse Headache – Findings From a Large Cohort.
45. Factors associated to chronic migraine with medication overuse: A cross-sectional study
46. Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers
47. Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients
48. Clinical features of migraine aura: Results from a prospective diary-aided study
49. Migraine aura symptoms: Duration, succession and temporal relationship to headache
50. Extraction of Clinical Information from Clinical Reports: an Application to the Study of Medication Overuse Headaches in Italy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.